Stockscreener 앱 받기
14.27
6.12%
-0.93
시장 영업 전:
14.84
0.57
+3.99%
전일 마감가:
$15.20
열려 있는:
$14.51
하루 거래량:
5,062
Relative Volume:
0.45
시가총액:
$30.64M
수익:
-
순이익/손실:
$-31.19M
주가수익비율:
-0.5046
EPS:
-28.2788
순현금흐름:
$-28.76M
1주 성능:
-7.34%
1개월 성능:
-28.29%
6개월 성능:
-26.82%
1년 성능:
+157.12%
1일 변동 폭
$14.26
$14.51
1주일 범위
$13.00
$15.96
52주 변동 폭
$3.659
$42.12
아폴로믹스 Stock (APLM) Company Profile
Compare APLM vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
14.27 | 32.64M | 0 | -31.19M | -28.76M | -28.28 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
아폴로믹스 주식(APLM)의 최신 뉴스
[Form 3/A] Apollomics Inc. Amended Initial Statement of Beneficial Ownership - Stock Titan
Apollomics (APLM) director Jan Chen-Huan reports 1,000 RSUs and 1,000 shares - Stock Titan
Apollomics (APLM) CFO details 20,000 RSUs and 15,900 shares in Form 3/A - Stock Titan
Apollomics (ticker: APLM) CEO details direct and indirect share stakes - Stock Titan
Apollomics (APLM) director discloses 1,000 restricted stock units award - Stock Titan
Apollomics (APLM) COO details RSU grants and Maxpro warrant stakes - Stock Titan
Apollomics (APLM) director Huang Ya-Chi details RSU vesting and share holdings - Stock Titan
Tech Rally: Does Apollomics Inc Equity Warrant have pricing power2026 PreEarnings & Fast Entry Momentum Alerts - baoquankhu1.vn
Market Outlook: Is Apollomics Inc in a consolidation phase2026 Bull vs Bear & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Bear Alert: Can Apollomics Inc stock outperform in a bear marketWeekly Stock Analysis & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Bond Watch: Can Apollomics Inc Equity Warrant expand its profit marginsEarnings Miss & Smart Swing Trading Techniques - baoquankhu1.vn
Aug Wrap: Will Apollomics Inc Equity Warrant outperform the market in YEARJobs Report & Long Hold Capital Preservation Tips - baoquankhu1.vn
Risk Off: Is Apollomics Inc attractive at current valuation2026 Analyst Calls & Long-Term Capital Growth Ideas - baoquankhu1.vn
Apollomics, Inc. (APLM) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Yi-Kuei Chen Discloses Investment at Apollomics Inc. with 5.3% Stake - TradingView — Track All Markets
Apollomics (APLM) COO Yi-Kuei Chen discloses 5.3% ownership stake in latest filing - Stock Titan
Aug PostEarnings: Is Apollomics Inc subject to activist investor interestWeekly Trend Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Growth Review: Is Apollomics Inc subject to activist investor interest2026 Market WrapUp & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Apollomics (APLM) chair reports 41.8% stake and $2M convertible bridge loan - Stock Titan
APLM SEC FilingsAPOLLOMICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Apollomics secures $2M convertible note from CEO Chen By Investing.com - Investing.com South Africa
Apollomics Inc. Secures $2 Million Bridge Financing to Support Biotechnology Initiatives - geneonline.com
Apollomics secures $2M bridge financing from CEO - MSN
Apollomics, Inc. (APLM) stock price, news, quote and history - Yahoo Finance UK
CEO funds Apollomics (Nasdaq: APLM) with $2M zero-interest convertible note - Stock Titan
Apollomics secures $2M convertible note from CEO Chen - Investing.com
Apollomics Inc. Announces $2.0 Million Bridge Financing - MarketScreener
Biotech Apollomics gets $2M from its CEO to fund clinical programs - Stock Titan
Dividend Watch: What is the cash position of Apollomics Inc Equity WarrantPortfolio Risk Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Market Pulse: Will Apollomics Inc benefit from sector rotation2026 Breakouts & Breakdowns & Verified Short-Term Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Guidance Update: What is the earnings history of Apollomics IncTrend Reversal & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Trend Review: Is Apollomics Inc in a consolidation phase2026 Setups & Daily Momentum Trading Reports - baoquankhu1.vn
Jobs Data: What makes Apollomics Inc stock attractive today2026 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Hedge Fund Bets: Can Apollomics Inc Equity Warrant grow without external funding2026 Geopolitical Influence & Technical Pattern Recognition Alerts - baoquankhu1.vn
Published on: 2026-03-26 20:31:32 - baoquankhu1.vn
Aug Final Week: What is the earnings history of Apollomics Inc2026 Technicals & Short-Term Swing Trade Alerts - baoquankhu1.vn
Layoff Watch: How does Apollomics Inc Equity Warrant compare to its peers2026 Year in Review & Smart Money Movement Alerts - baoquankhu1.vn
Understanding the Setup: (APLM) and Scalable Risk - Stock Traders Daily
Market Outlook: Is Apollomics Inc a potential multi baggerEarnings Recap Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Inflation Data: What drives Apollomics Inc Equity Warrants stock price2026 Geopolitical Influence & Proven Capital Preservation Tips - baoquankhu1.vn
Apollomics (APLM) CEO Chen Hung-Wen details direct, indirect shares and RSUs - Stock Titan
APLMW SEC FilingsAPOLLOMICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Apollomics (APLM) director Hong-Jung Chen discloses initial shares, RSUs, options and warrants - Stock Titan
Apollomics (APLM) director Huang Ya-Chi discloses 2,000 RSU grant in Form 3 - Stock Titan
Director CHU YI-AN discloses 2,000 RSUs in Apollomics (APLM) - Stock Titan
Director in Apollomics (APLM) reports 2,000 restricted stock units on Form 3 - Stock Titan
Apollomics (APLM) director discloses 2,000 RSUs and vesting schedule - Stock Titan
Apollomics (APLM) COO Chen Yi-Kuei reports RSUs, shares and warrants on Form 3 - Stock Titan
[Form 3] Apollomics Inc. Initial Statem... - Stock Titan
Exit Recap: Does Apollomics Inc Equity Warrant outperform in volatile marketsWeekly Earnings Recap & Free Accurate Trade Setup Notifications - baoquankhu1.vn
아폴로믹스 (APLM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):